Welcome to an overview of the American College of Cardiology's Cardiovascular Ambulatory Surgery Center, or CVASC, registry suite. The objectives for this presentation are for the learner to be able to define the purpose and background of the registry, identify the procedures which comprise each of the four pathways recognizing the applicable patient population for these procedure pathways, and to understand the role of the CVASC registry suite governance structure. The number of minimally invasive elective cardiac procedures being performed in the outpatient setting has increased significantly in recent years. However, a registry to collect data and monitor patient outcomes while giving outpatient centers a tool and the resources to support their quality improvement efforts did not exist. To meet that need, the ACC's National Cardiovascular Data Registry, NCDR, has launched the CVASC registry suite, the first unified registry for cardiac procedures performed in the outpatient space. The registry was developed from extensive market research and expertise from the ASC administrators and clinicians. The CVASC registry suite was designed to support various types of outpatient facilities, ambulatory surgery centers, or ASCs, office-based labs, or OBLs, or when a single center functions as both in a hybrid setting. To accommodate all scenarios, the data collection process supports identifying the facility type under which the patient received care. The data collection process was designed to be easily integrated into the established outpatient workflow, yet also aligns closely with the NCDR's in-hospital counterparts, the cath PCI registry and the EP device implant registry. This allows that ASC facilities will be able to compare their registry metric performances to like ASC facilities, as well as compare their metric performance to like patients who received in-hospital care. These data will support deeper insights and may lead to advanced quality improvement initiatives. The registry is a rich source of data where participants can compare their metric performance to various benchmarks and may support identifying efficiency rates, emergent transfer rates, as well as note important indicators such as bleeding or other procedure complications. The data collection structure was designed by a cross-sectional team which developed novel approaches for data collection and a dynamic and interactive dashboard to support registry participants. Coronary artery disease is a significant epidemiological disease affecting the U.S. population. The CDC identifies CAD as the leading cause of death in men, women, and most ethnic groups in the United States with nearly 1 in 20 adults who are age 20 or older having CAD, which is about 5% of the population. The safest and most cost-effective treatment for advanced disease is percutaneous coronary angiography. Heart failure affects about 6.2 million adults in the United States and costs the nation an estimated $30 billion that includes health care services, medicines to treat heart failure, and missed days of work. Patients who have cardiac pathology, such as heart failure, have a higher risk of developing a life-threatening arrhythmia. An implantable cardioverter defibrillator, or ICD, is effective in detecting and terminating these abnormal rhythms. A progressive decline in maximum heart rate is seen as human's age and is independent of gender, fitness, and lifestyle and affects both men and women alike. Cardiac pacemakers are effective in treating symptomatic bradycardia and slow or irregular rhythms. The CV ASC registry suite includes pathways for diagnostic coronary angiography and percutaneous coronary interventions. Eligible patients include those who are greater than or equal to 18 years of age. A diagnostic coronary angiography procedure involves the passage of a catheter into the aortic root or other great vessels for the purpose of angiography of the native coronary arteries or bypass grafts supplying the native coronary arteries. Percutaneous coronary intervention procedures include the placement of a guide wire, balloon, or other device such as a stent, arthrectomy, brachytherapy, or thrombectomy catheter into a native coronary artery or coronary artery bypass graft for the purpose of mechanical coronary revascularization. Additionally, the CV ASC registry suite offers procedure pathways for permanent pacemakers PPM and implantable cardioverter defibrillators ICD for patients of all ages. The placement of these life-sustaining and life-saving implantable devices support patients by using electrical impulses or electrical shocks to either sustain a normal heart rate or interrupt an irregular one. The CV ASC registry governance is shared by both the Cath PCI and the EP Device Implant Steering Committees. Each committee is comprised of 7 to 10 members with representatives from the NCDR Oversight Committee and other stakeholders such as the Society for Cardiovascular Angiography and Interventions. Each steering committee will monitor and guide the respective procedure pathways and the metrics those support. Steering committee members have expertise in clinical practice and research, financial management, quality measurement and improvement, and or health system strategy and innovation. They'll provide strategic oversight of the registry program by offering guidance for registry activities, help identify metric opportunities, and help determine priorities. This concludes the introduction to the CV ASC registry suite. Thank you for taking the time to become better acquainted with this innovative quality improvement initiative of the American College of Cardiology.

CVASC Registry Suite

cardiac procedure data

outpatient settings

patient outcomes

quality improvement

American College of Cardiology

outpatient cardiac procedures

quality improvement efforts